Stephen From - Nov 2, 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
Executive Chairman, Director
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Nov 2, 2021
Transactions value $
-$495
Form type
4
Date filed
11/3/2021, 04:16 PM
Previous filing
Oct 5, 2021
Next filing
Dec 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$495 -250 -0.36% $1.98 68.3K Nov 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021.